These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3691871)

  • 21. [Immune damage to the heart and blood vessels].
    Moĭbenko AA; Butenko GM
    Fiziol Zh (1978); 1981; 27(5):587-94. PubMed ID: 7297706
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of alcohol, nicotine and cigarette smoking on the heart].
    Robin E; Ravens KG; Bing RJ
    Dtsch Med J; 1969 Jan; 20(1):19-29. PubMed ID: 4891604
    [No Abstract]   [Full Text] [Related]  

  • 23. [Coronary hemodynamics and myocardial metabolism in primary dilated-type myocardiopathy].
    Pornin M; Sellier P; Lardoux H; Duong TC; Ourbak P; Maurice P
    Arch Mal Coeur Vaiss; 1980 Aug; 73(8):951-60. PubMed ID: 6774684
    [No Abstract]   [Full Text] [Related]  

  • 24. [Reactions of capillaries and small vessels to administration of anticardiac cytotoxic serum].
    Sirotina MF
    Fiziol Zh; 1975; 21(2):188-94. PubMed ID: 1126475
    [No Abstract]   [Full Text] [Related]  

  • 25. Wide-spread myocardial remodeling after acute myocardial infarction in rat. Features for heart failure progression.
    Krzemiński TF; Nozyński JK; Grzyb J; Porc M
    Vascul Pharmacol; 2008; 48(2-3):100-8. PubMed ID: 18276196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Mechanisms of blood deposition in dogs with a cytotoxic heart lesion].
    Sagach VF
    Biull Eksp Biol Med; 1979 Jun; 87(6):533-6. PubMed ID: 37939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in the vascular wall and ischemic damages to the myocardium in reversible episodes of heart muscle ischemia].
    Pozin VM; Skuratovskaia SG; Pocheptsova GA
    Fiziol Zh (1994); 1996; 42(1-2):10-6. PubMed ID: 8991704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of immune sera of different specificities on the heart].
    Shablovskaia OV; Sagach VF; Popovich LF
    Fiziol Zh (1978); 1985; 31(1):38-44. PubMed ID: 3979596
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative characteristics of the effect of anticardiac and antiseroprotein sera on cardio- and hemodynamics in dogs].
    Sagach VF; Shablovskaia OV; Zaichenko AP
    Fiziol Zh (1978); 1978; 24(6):788-93. PubMed ID: 720658
    [No Abstract]   [Full Text] [Related]  

  • 30. [The cardioprotective effect of perindopril in rats with experimental cardiosclerosis].
    Kalenikova EI; Gorodetskaia EA; Zakharova NV; Kuznetsova TV; Medvedev OS
    Eksp Klin Farmakol; 1999; 62(2):16-8. PubMed ID: 10340121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future directions for nonclinical evaluation.
    Hood WB
    Circulation; 1983 Aug; 68(2 Pt 2):I98-104. PubMed ID: 6407778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Modeling of myocardial lesions of varying degrees of manifestation].
    Reznikov KM; Leonov AN; Kitaeva RI; Bykov EG; Provotorova PP
    Biull Eksp Biol Med; 1985 May; 99(5):532-4. PubMed ID: 4005403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Experimental myocardial infarct. Preliminary report. 1. Hemodynamics, electrolytes in the myocardial tissue and coronary vein, blood morphology. Effects of Trasylol].
    Tschirkov F; Greifenstein J; Eisenbach J; Röttger P; Heine H
    Med Welt; 1972 Dec; 23(49):1838-43. PubMed ID: 4539560
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cardioprotective effect of exogenous phosphocreatine in patients undergoing open heart surgery].
    Cheng SX; Hu QH
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):353-5. PubMed ID: 12536735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Morphologic and biochemical criteria of the efficacy of clinical use of phosphocreatine (neoton) for intraoperative protection of the myocardium].
    Chazov EI; Semenovskiĭ ML; Smirnov VN; Shumakov VI; Saks VA
    Fiziol Zh (1978); 1986; 32(1):3-13. PubMed ID: 3956779
    [No Abstract]   [Full Text] [Related]  

  • 36. Phosphocreatine restores high-energy phosphates in ischemic myocardium: implication for off-pump cardiac revascularization.
    Prabhakar G; Vona-Davis L; Murray D; Lakhani P; Murray G
    J Am Coll Surg; 2003 Nov; 197(5):786-91. PubMed ID: 14585415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of neoton on the course of unstable angina].
    Golikov AP; Riabinin VA; Taranova ZV; Rudnev DV; Davydov BV
    Ter Arkh; 1994; 66(2):58-60. PubMed ID: 8160149
    [No Abstract]   [Full Text] [Related]  

  • 38. [The current possibilities for the pharmacological regulation of myocardial metabolism in experimental catecholamine-induced necroses].
    Sysoliatina NA; Artamonova VV
    Eksp Klin Farmakol; 1998; 61(1):70-3. PubMed ID: 9575418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Morphological changes in the heart in the reproduction of different types of allergic reaction].
    Popovich LF; Sagach VF; Moĭbenko AA
    Fiziol Zh (1978); 1987; 33(4):8-16. PubMed ID: 2957242
    [No Abstract]   [Full Text] [Related]  

  • 40. [Exogenous phosphocreatine in the prevention and treatment of cardiac insufficiency in patients with myocardial infarction].
    Perepech NB; Nedoshivin AO; Kutuzova AE
    Klin Med (Mosk); 1993 Jan; 71(1):19-22. PubMed ID: 8046897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.